Literature DB >> 35015221

Treatment Progress in Diminished Ovarian Reserve: Western and Chinese Medicine.

Qiao-Li Zhang1, Ya-Ling Lei2, Yan Deng3, Rui-Lin Ma3, Xue-Song Ding3, Wei Xue3, Ai-Jun Sun4.   

Abstract

Diminished ovarian reserve (DOR), generally defined as a decreased number or quality of oocytes, has a significant impact on quality of life and fertility in women. In recent years, the incidence of DOR has been increasing and the ages of patients are younger. The search for an effective DOR treatment has emerged as one of the preeminent research topics in reproductive health. An effective DOR therapy would improve ovarian function, fertility, and quality of life in patients. In this review we evaluated DOR treatment progress both in Western medicine and Chinese medicine, and elucidated the characteristics of each treatment.
© 2021. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Chinese medicine; Western medicine; diminished ovarian reserve; treatment

Year:  2022        PMID: 35015221     DOI: 10.1007/s11655-021-3353-2

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  32 in total

1.  Diminished ovarian reserve, premature ovarian failure, poor ovarian responder--a plea for universal definitions.

Authors:  J Cohen; N Chabbert-Buffet; E Darai
Journal:  J Assist Reprod Genet       Date:  2015-10-13       Impact factor: 3.412

2.  Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System.

Authors:  Kate Devine; Sunni L Mumford; Mae Wu; Alan H DeCherney; Micah J Hill; Anthony Propst
Journal:  Fertil Steril       Date:  2015-06-11       Impact factor: 7.329

3.  Multivitamin and mineral supplementation modulates oxidative stress and antioxidant vitamin levels in serum and follicular fluid of women undergoing in vitro fertilization.

Authors:  M Okan Ozkaya; Mustafa Nazıroğlu
Journal:  Fertil Steril       Date:  2010-03-12       Impact factor: 7.329

4.  Klotho: spinning up some new hype for decreased ovarian reserve research?

Authors:  Trenton L Place; Lynda K McGinnis
Journal:  Fertil Steril       Date:  2020-10-09       Impact factor: 7.329

5.  Relationship between diminished ovarian reserve and mitochondrial biogenesis in cumulus cells.

Authors:  L Boucret; J M Chao de la Barca; C Morinière; V Desquiret; V Ferré-L'Hôtellier; P Descamps; C Marcaillou; P Reynier; V Procaccio; P May-Panloup
Journal:  Hum Reprod       Date:  2015-05-20       Impact factor: 6.918

Review 6.  Genetic associations with diminished ovarian reserve: a systematic review of the literature.

Authors:  Alexis D Greene; George Patounakis; James H Segars
Journal:  J Assist Reprod Genet       Date:  2014-05-20       Impact factor: 3.412

7.  Diminished ovarian reserve versus ovarian aging: overlaps and differences.

Authors:  Baris Ata; Ayse Seyhan; Emre Seli
Journal:  Curr Opin Obstet Gynecol       Date:  2019-06       Impact factor: 1.927

8.  Can Coenzyme Q10 supplementation protect the ovarian reserve against oxidative damage?

Authors:  Pınar Özcan; Cem Fıçıcıoğlu; Ozge Kizilkale; Mert Yesiladali; Olgu Enis Tok; Ferda Ozkan; Mukaddes Esrefoglu
Journal:  J Assist Reprod Genet       Date:  2016-06-03       Impact factor: 3.412

9.  The role of melatonin as an antioxidant in the follicle.

Authors:  Hiroshi Tamura; Akihisa Takasaki; Toshiaki Taketani; Manabu Tanabe; Fumie Kizuka; Lifa Lee; Isao Tamura; Ryo Maekawa; Hiromi Aasada; Yoshiaki Yamagata; Norihiro Sugino
Journal:  J Ovarian Res       Date:  2012-01-26       Impact factor: 4.234

10.  Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial.

Authors:  Yangying Xu; Victoria Nisenblat; Cuiling Lu; Rong Li; Jie Qiao; Xiumei Zhen; Shuyu Wang
Journal:  Reprod Biol Endocrinol       Date:  2018-03-27       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.